CH
VRNA

CVI Holdings’s Verona Pharma VRNA Stock Holding History

CVI Holdings’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-178,273
Closed -$1.25M – 631
2020
Q4 		$1.25M Sell
178,273
-266,172
-60% -$1.8M 0.23% 101
2020
Q3 		$2.77M Buy
+444,445
New +$3.07M 1.13% 25

Other funds holding VRNA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

CVI Holdings's VRNA Position: Q1 2021 in Review

CVI Holdings sold out of Verona Pharma (VRNA) in Q1 2021, closing a stake of 178,273 shares — an estimated $1.25M sold.

CVI Holdings first reported a position in VRNA in Q3 2020 and held it in 2 quarters. The position peaked at $2.77M in Q3 2020. 37 funds tracked by Wall St. Rank hold VRNA as of Q1 2021.

  • CVI Holdings reported no remaining Verona Pharma position as of Q1 2021 after selling out during the quarter.
  • CVI Holdings sold 178,273 Verona Pharma shares in Q1 2021, an estimated $1.25M.
  • CVI Holdings first reported a position in Verona Pharma in Q3 2020 and held it in 2 quarters.
  • CVI Holdings's Verona Pharma position peaked at $2.77M in Q3 2020.
  • 37 funds tracked by Wall St. Rank held Verona Pharma as of Q1 2021.

Based on CVI Holdings's 13F filing for Q1 2021, filed 17 May 2021.